MicroPort CardioFlow Medtech (2160.HK) Earnings Analysis
MicroPort CardioFlow Medtech (2160.HK) next reports earnings on 2026-09-02. Trailing P/E -0.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2160.HK next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2160.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-26 | -0.00508 HKD | n/a | n/a | n/a |
| 2024-08-28 | -0.12913 HKD | n/a | n/a | n/a |
2160.HK valuation and analyst view
| Trailing P/E | -0.68 |
|---|---|
| Trailing EPS | -1.48914 HKD |
| Price / book | 0.05 |
| Dividend yield | 0.00% |
| Market cap | 0.48B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is MicroPort CardioFlow Medtech (2160.HK)'s next earnings date?
MicroPort CardioFlow Medtech is next scheduled to report on 2026-09-02.
Did 2160.HK beat earnings last quarter?
Consensus estimate data was not available for 2160.HK's 2025-08-26 report.
What is 2160.HK's current P/E ratio and EPS?
2160.HK trades at a trailing P/E of -0.68 on trailing EPS of -1.48914232372228 HKD.
What do analysts rate 2160.HK?
2160.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.